PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Global LVADs market • Global BiVADs market • Global RVADs market PART 07: Market segmentation by application • BTT therapy • BTD therapy • Destination therapy • BTR therapy PART 08: Market segmentation by end-user • ASCs • Hospitals • Physicians' offices PART 09: Geographical segmentation • VADs market in Americas • VADs market in EMEA • VADs market in APAC PART 10: Market drivers • Shortage of heart donors and high cost of heart transplantation • Favorable reimbursement scenario • Outsourcing research studies on VADs to CROs • Focus on unmet needs for advanced heart failure PART 11: Impact of drivers PART 12: Market challenges • Availability of alternative treatments • Product recalls • Regulatory complications • Complications associated with VADs PART 13: Impact of drivers and challenges PART 14: Market trends • Advances in technology • Market strategies used by small companies for market penetration • Increase in M&A • Focus on evidence-based research PART 15: Vendor landscape • Competitive scenario • Market share analysis 2015 • PART 16: Major vendors • ABIOMED • Berlin Heart • HeartWare • St. Jude Medical • Other prominent vendors PART 17: Appendix • List of abbreviations PART 18: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Worldwide prevalence of heart failure 2015 Exhibit 03: VADs: Technological developments Exhibit 04: Global VADs market Exhibit 05: Market scenario of LVADs, BiVADs, and RVADs Exhibit 06: LVADs: Significant clinical outcomes Exhibit 07: Global VADs market 2015-2020 ($ billions) Exhibit 08: Five forces analysis Exhibit 09: Global VADs market segmentation by product 2015 Exhibit 10: Global VADs market segmentation by product 2020 Exhibit 11: Global LVADs market: An overview Exhibit 12: Global LVADs market 2015-2020 ($ billions) Exhibit 13: Global LVADs market: Metrics analysis Exhibit 14: Global BiVADs market: An overview Exhibit 15: Global BiVADs market 2015-2020 ($ millions) Exhibit 16: Global BiVADs market: Metrics analysis Exhibit 17: Global RVADs market: An overview Exhibit 18: Global RVADs market 2015-2020 ($ millions) Exhibit 19: Global RVADs market: Metrics analysis Exhibit 20: Global VAD market segmentation by application 2015 Exhibit 21: Overview of BTT therapy involving VADs Exhibit 22: Overview of BTD therapy involving VADs Exhibit 23: Overview of destination therapy involving VADs Exhibit 24: Overview of BTR therapy involving VADs Exhibit 25: Global VAD market segmentation by end-user 2015 Exhibit 26: Global VADs market segmentation by geography 2015 and 2020 Exhibit 27: Global VADs market segmentation by geography 2015-2020 Exhibit 28: Global VADs market segmentation by geography 2015-2020 ($ millions) Exhibit 29: VADs market in Americas: An overview Exhibit 30: Hospital admission for congestive heart failure per 100,000 individuals in some countries in Americas 2008 and 2013 Exhibit 31: VADs market in Americas 2015-2020 ($ millions) Exhibit 32: VADs market in Americas: Metrics analysis for various countries Exhibit 33: VADs market in US: PEST analysis Exhibit 34: Implements amended in ACA in US Exhibit 35: Impact of ACO and ACA on VADs Exhibit 36: VADs market in EMEA: An overview Exhibit 37: Hospital admission for congestive heart failure per 100,000 individuals in few countries in EMEA 2008 and 2013 Exhibit 38: VADs market in EMEA 2015-2020 ($ millions) Exhibit 39: VADs market in EMEA: Metrics analysis for various countries Exhibit 40: VADs market in UK: PEST analysis Exhibit 41: VAD market in APAC Exhibit 42: Hospital admission for congestive heart failure per 100,000 individuals in few countries in APAC 2008 and 2013 Exhibit 43: VADs market in APAC 2015-2020 ($ millions) Exhibit 44: VADs market in APAC: Metrics analysis for various countries Exhibit 45: VADs market in Japan: PEST analysis Exhibit 46: Estimated number of people in various countries awaiting heart transplantation 2014 Exhibit 47: Estimated reimbursement cost in various countries Exhibit 48: CROs that helped companies receive regulatory approval for VADs Exhibit 49: Impact of drivers Exhibit 50: Product recalls: VADs Exhibit 51: VADs under investigational use Exhibit 52: Impact of drivers and challenges Exhibit 53: Advanced products and their market impact Exhibit 54: Market strategies and their impact Exhibit 55: Acquisitions by some companies Exhibit 56: Global VADs market: Competitive landscape analysis 2015 Exhibit 57: Global VADs market share analysis 2015 Exhibit 58: ABIOMED: Metrics analysis Exhibit 59: Berlin Heart: Metrics analysis Exhibit 60: HeartWare: Metrics analysis Exhibit 61: St. Jude Medical: Metrics analysis Exhibit 62: Other prominent vendors

ABIOMED, Berlin Heart, HeartWare, St. Jude Medical, CardiacAssist Technologies, CORWAVE, EVAHEART, Jarvik Heart, Leviticus Cardio, ReliantHeart, Sunshine Heart, Ventracor.